Ipca Laboratories reports 6% fall in Q2 consolidated net profit

13 Nov 2023 Evaluate

Ipca Laboratories has reported results for second quarter ended September 30, 2023 (Q2FY24). 

The company has reported 2.11% fall in its net profit at Rs 162.13 crore for the quarter under review as compared to Rs 165.63 crore for the same quarter in the previous year. However, total income of the company increased by 11.02% at Rs 1,698.81 crore for Q2FY24 as compared to Rs 1,530.16 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 6.39% fall in its net profit at Rs 137.44 crore for Q2FY24 as compared to Rs 146.82 crore for the same quarter in the previous year. However, total income of the company increased by 26.59% at Rs 2,072.51 crore for Q2FY24 as compared to Rs 1,637.18 crore for the corresponding quarter previous year.

Ipca Laboratories Share Price

1340.00 3.90 (0.29%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.